台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    102.5
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    33
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
智基 (6294)籌碼相關-元富-世貿 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元富-世貿 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/300103.5000.00102.5001590.02%
2024/05/291102.5000.00102.5011590.63%
2024/05/282102.7500.00102.5021581.26%
2024/05/230103.5000.00102.5001570.02%
2024/05/150106.0000.00104.0001480.02%
2024/05/140103.0000.00102.0001440.02%
2024/05/130.1107.7400.00107.000.11270.05%
2024/05/030119.0000.00118.5001170.01%
2024/04/150.1117.5000.00117.000.11070.05%
2024/04/120118.0000.00118.0001040.02%
2024/04/1100.000119.38119.500101-0.01%
2024/04/100127.7200.00127.000950.01%
2024/04/020123.5000.00123.500700.03%
2024/04/010.1123.5000.00123.000.1690.14%
2024/03/260.1124.0000.00123.000.1630.16%
2024/03/220124.0000.00122.500600.04%
2024/03/180.1124.0000.00124.000.1510.10%
2024/03/140.1119.5000.00119.000.1430.14%
2024/03/120116.5000.00117.000380.06%
2024/03/110.1114.5000.00114.500.1360.14%
2024/02/260.1113.0000.00112.000.1320.15%
2024/02/150.1112.0000.00112.000.1310.23%
2024/01/180.1111.5000.00111.000.1290.17%
2024/01/120.1112.0000.00112.000.1290.24%
2024/01/040.1115.0000.00114.500.1250.19%
2023/12/120.1114.0000.00113.000.1220.23%
2023/12/0800.000.1114.00114.50-0.121-0.47%
2023/11/130.1113.5000.00112.500.1210.24%
2023/10/170116.5000.00117.000240.16%
2023/09/250.1114.0000.00114.000.1260.19%
2023/09/180.1114.5000.00115.000.1260.37%
2023/09/140.3114.0000.00114.500.3260.95%
2023/08/280.1112.0000.00110.500.1300.33%
2023/08/160.1112.501112.50112.50-130-3.15%
2023/07/2400.000.1110.50110.00-0.130-0.33%
2023/07/060.1108.0000.00107.500.1420.23%
2023/06/121107.0000.00108.501541.84%
2023/06/070.1108.5000.00109.000.1540.18%
2023/05/2200.000.5108.50109.00-0.556-0.87%
2023/05/1900.000.1108.00108.50-0.155-0.14%
2023/05/040.1109.0000.00109.500.1520.19%
2023/04/140.1112.0000.00111.000.1500.20%
2023/04/111121.0000.00121.001402.48%
2023/04/060.1119.5000.00120.000.1370.13%
2023/03/2700.001118.00117.50-133-2.96%
2023/03/131111.0000.00111.001342.90%
2023/01/3100.000.1108.50108.00-0.139-0.25%
2022/12/2300.001.3103.00103.00-1.338-3.36%
2022/12/140.1103.0000.00103.500.1380.26%
2022/12/010.1100.5000.00100.000.1290.17%
2022/10/270.1101.0000.00100.000.1160.60%
2022/10/21199.9000.00100.001156.42%
2022/10/190.1102.5000.00101.000.1150.63%
2022/10/110.1104.0000.00104.000.1160.62%
2022/10/040.1106.0000.00104.000.1160.60%
2022/10/030.1104.5000.00103.500.1160.60%
2022/04/1500.001125.00124.50-125-3.88%
2022/03/011125.5000.00126.001224.48%
2022/02/151125.5000.00124.501204.79%
2021/04/0900.001145.00145.50-135-2.84%
2021/03/291143.0000.00143.501283.49%
2021/01/0500.000.1124.00124.00-0.132-0.34%
2020/06/0900.000.1113.50113.50-0.155-0.25%
2020/05/1100.001105.50106.00-144-2.24%
2020/03/0900.000100.00100.00027-0.04%
2020/01/140102.0000.00102.000230.04%
2019/08/0600.001102.00102.50-144-2.26%
2019/07/261102.0000.00102.001462.17%
2019/07/241103.0000.00103.001452.18%
2019/05/1000.001109.00108.50-141-2.40%
2019/04/0200.0019107.00107.50-1934-55.47%
2019/03/2800.0037108.15108.50-3731-116.97%
2019/03/1900.001111.00111.50-128-3.45%
2019/03/141110.0000.00110.001253.92%
2019/03/1300.001110.00110.00-125-3.92%
2019/03/1200.001109.50109.50-125-3.91%
2019/03/081109.0000.00109.001253.90%
2019/02/256109.2500.00110.0062325.04%
2019/02/215108.8000.00108.0052321.51%
2019/02/207108.2100.00108.5072330.22%
2019/02/148107.7500.00108.5082137.27%
2019/02/136106.7500.00107.0062127.95%
2019/01/281105.5000.00106.001224.40%
2019/01/1514107.4300.00106.50142555.56%
2019/01/0910105.6000.00104.50102440.08%
2018/09/0500.000.2108.00108.50-0.252-0.38%
2018/08/091111.0000.00111.001611.63%
2018/08/0200.002112.00112.50-269-2.88%
2018/07/191125.0000.00125.501831.20%
2018/07/181125.5000.00125.501831.19%
2018/06/2600.001123.00124.50-193-1.06%
2018/06/251125.0000.00124.001931.06%
2018/01/3000.0014121.00120.00-14162-8.60%
2018/01/2600.002123.00122.50-2161-1.23%
2018/01/2300.001122.50123.00-1155-0.64%
2018/01/192127.2500.00124.0021481.35%
2018/01/1715119.8700.00121.501512911.57%
2018/01/1600.001118.00116.00-1118-0.84%
2018/01/051112.0000.00112.001991.00%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音